Skip to main content

and
  1. Article

    Open Access

    Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study

    Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients. There are few data outside cli...

    Claudia Palladino, Marta Sánchez-Carrillo, Irene Mate-Cano in Scientific Reports (2017)

  2. Article

    Open Access

    Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain

    Hepatitis C virus (HCV) infection remains a global health problem. Previously, the prevalence of NS5A resistance-associated substitutions (RASs) to elbasvir, a new direct-acting antiviral (DAA) against the NS5...

    Claudia Palladino, Ifeanyi Jude Ezeonwumelu, Irene Mate-Cano in Scientific Reports (2020)